{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:00:01Z","timestamp":1781614801132,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a scarcity of randomized and high-quality studies to aid clinicians in management and treatment of Wilson disease (WD). Even amongst society practice guidelines in North America and Europe, diagnosis and management of WD varies. The aim of this study is to elucidate WD diagnosis and treatment patterns by conducting a survey of clinicians in California and comparing the results to clinicians in Italy as a representation of European practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a 51-item survey assessing WD diagnostics, therapeutics, and disease monitoring. The survey was distributed through email to 1330 California gastroenterologists, hepatologists, and movement neurologists and to multiple Italian academic medical centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-two providers in California completed the survey encompassing a total of 236 patients. Twenty-three providers in Italy with a total of 390 patients in their care responded. About half of California providers perform a full neurologic evaluation before initiating therapy in patients with predominantly hepatic presentation while 71% of Italian providers perform one. In patients with predominantly hepatic presentation, 47.4% of California providers use trientine as initial therapy, 26.3% use d-penicillamine, and 10.5% use combination therapy with chelators and zinc. No one reported using zinc monotherapy as initial treatment. Italian providers report using d-penicillamine as initial therapy in 85% of cases, followed by zinc salt (10%), and none uses trientine. WD patients on combination therapy with chelators and zinc are followed by 34% of California respondents and 32% of Italian respondents. In patients with predominantly neurologic manifestations, initial therapy choices are variable with 38.9% of California providers using d-penicillamine, 16.7% using zinc salts, 11.1% using trientine, and 22% using other therapies. 55% of Italian providers use d-penicillamine, 20% combination chelator and zinc, 15%, trientine and 10% zinc salts. Changing from initial therapy to maintenance therapy in both surveys occur after stabilization of clinical presentation, liver function tests, and 24-hour urinary copper in 72% and 86% of California and Italian providers respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings highlight the significant variability in initial therapies for WD amongst California and European\/Italian providers. Despite the wide use of combination therapy of chelators and zinc, its needs further exploration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41043-025-01072-1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:41:10Z","timestamp":1759236070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative management practices of Wilson disease in Californian and Italian providers"],"prefix":"10.1186","volume":"44","author":[{"given":"Sandy","family":"Vien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Medici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"1072_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann O, Weiss KH, Kaler SG. Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103\u201313.","journal-title":"Lancet Neurol"},{"issue":"9559","key":"1072_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"A Ala","year":"2007","unstructured":"Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson\u2019s disease. Lancet. 2007;369(9559):397\u2013408.","journal-title":"Lancet"},{"issue":"Pt 5","key":"1072_CR3","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awt035","volume":"136","author":"AJ Coffey","year":"2013","unstructured":"Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, et al. A genetic study of wilson\u2019s disease in the united Kingdom. Brain J Neurol. 2013;136(Pt 5):1476\u201387.","journal-title":"Brain J Neurol"},{"issue":"6","key":"1072_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clinre.2018.03.007","volume":"42","author":"A Poujois","year":"2018","unstructured":"Poujois A, Woimant F. Wilson\u2019s disease: A 2017 update. Clin Res Hepatol Gastroenterol. 2018;42(6):512\u201320.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1072_CR5","doi-asserted-by":"publisher","unstructured":"Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology [Internet]. 2022 Dec 7 [cited 2024 Nov 26]; Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1002\/hep.32801","DOI":"10.1002\/hep.32801"},{"issue":"4","key":"1072_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cgh.2013.09.025","volume":"12","author":"S Beinhardt","year":"2014","unstructured":"Beinhardt S, Leiss W, St\u00e4ttermayer AF, Graziadei I, Zoller H, Stauber R, et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol. 2014;12(4):683\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"S2","key":"1072_CR7","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.21037\/atm.2019.02.10","volume":"7","author":"A Poujois","year":"2019","unstructured":"Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med. 2019;7(S2):S67\u201367.","journal-title":"Ann Transl Med"},{"issue":"S2","key":"1072_CR8","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.21037\/atm.2018.12.53","volume":"7","author":"CS Palumbo","year":"2019","unstructured":"Palumbo CS, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med. 2019;7(S2):S65\u201365.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1072_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13023-023-02731-4","volume":"18","author":"S Zimny","year":"2023","unstructured":"Zimny S, Bourhis H, Weber S, Reiter FP, Hohenester S, Kraft E, et al. Medical care of patients with Wilson disease in germany: a multidisciplinary survey among university centers. Orphanet J Rare Dis. 2023;18(1):122.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1072_CR10","doi-asserted-by":"publisher","first-page":"e02168","DOI":"10.1002\/brb3.2168","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Wu Y, Yan Y, Liu A, Yu Q, Peng Z, et al. Persistence with medical treatment for Wilson disease in China based on a single center\u2019s survey research. Brain Behav. 2021;11(6):e02168.","journal-title":"Brain Behav"},{"issue":"5","key":"1072_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/03007995.2024.2337684","volume":"40","author":"J Vlasnik","year":"2024","unstructured":"Vlasnik J, Cambron-Mellott MJ, Costantino H, Kunjappu M. Burden of Wilson disease among patients and care partners in the united states: results from a cross-sectional survey. Curr Med Res Opin. 2024;40(5):863\u201376.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1072_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MPG.0000000000001102","volume":"63","author":"E Sturm","year":"2016","unstructured":"Sturm E, Piersma FE, Tanner MS, Socha P, Roberts EA, Shneider BL. Controversies and variation in diagnosing and treating children with Wilson disease: results of an international survey. J Pediatr Gastroenterol Nutr. 2016;63(1):82\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1072_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2024.11.007","volume":"82","author":"P Socha","year":"2025","unstructured":"Socha P, Ja\u0144czyk W, Zanetto A, Burra P, Czlonkowska A, Debray D, et al. EASL-ERN clinical practice guidelines on wilson\u2019s disease. J Hepatol. 2025;82(4):690\u2013728.","journal-title":"J Hepatol"},{"issue":"2","key":"1072_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MPG.0000000000001787","volume":"66","author":"P Socha","year":"2018","unstructured":"Socha P, Janczyk W, Dhawan A, Baumann U, D\u2019Antiga L, Tanner S, et al. Wilson\u2019s disease in children: A position paper by the hepatology committee of the European society for paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;66(2):334\u201344.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1072_CR15","doi-asserted-by":"publisher","first-page":"1299182","DOI":"10.3389\/fgstr.2023.1299182","volume":"2","author":"V Medici","year":"2024","unstructured":"Medici V, Kebede N, Stephens J, Kunjappu M, Vierling JM. Clinical signs and symptoms of Wilson disease in a real-world cohort of patients in the united states: a medical chart review study. Front Gastroenterol. 2024;2:1299182.","journal-title":"Front Gastroenterol"},{"key":"1072_CR16","doi-asserted-by":"publisher","first-page":"1363130","DOI":"10.3389\/fgstr.2024.1363130","volume":"3","author":"V Medici","year":"2024","unstructured":"Medici V, Kebede N, Stephens J, Kunjappu M, Vierling JM. Treatment patterns in a real-world cohort of patients with Wilson disease in the united States. Front Gastroenterol. 2024;3:1363130.","journal-title":"Front Gastroenterol"},{"key":"1072_CR17","doi-asserted-by":"crossref","unstructured":"Patel AH, Ghattu M, Mazzaferro N, Chen A, Catalano K, Minacapelli CD et al. Demographics and Outcomes Related to Wilson\u2019s Disease Patients: A Nationwide Inpatient Cohort Study. Cureus [Internet]. 2023 Sep 5 [cited 2024 Nov 27]; Available from: https:\/\/www.cureus.com\/articles\/165955-demographics-and-outcomes-related-to-wilsons-disease-patients-a-nationwide-inpatient-cohort-study","DOI":"10.7759\/cureus.44714"},{"key":"1072_CR18","unstructured":"Essential Source of Coverage for Millions [Internet]. Available from: https:\/\/www.chcf.org\/wp-content\/uploads\/2024\/06\/MediCalFactsFiguresAlmanac08052024.pdf"},{"key":"1072_CR19","unstructured":"B R. Organization and financing of public health services in europe: country reports. Geneva: World Health Organization; 2018. 1 p. (Health policy series)."},{"issue":"2","key":"1072_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/biomedicines11020420","volume":"11","author":"LC Penning","year":"2023","unstructured":"Penning LC, Berenguer M, Czlonkowska A, Double KL, Dusek P, Espin\u00f3s C, et al. A century of progress on Wilson disease and the enduring challenges of genetics, diagnosis, and treatment. Biomedicines. 2023;11(2):420.","journal-title":"Biomedicines"},{"issue":"1","key":"1072_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12913-023-09886-7","volume":"23","author":"T Willmen","year":"2023","unstructured":"Willmen T, Willmen L, Pankow A, Ronicke S, Gabriel H, Wagner AD. Rare diseases: why is a rapid referral to an expert center so important? BMC Health Serv Res. 2023;23(1):904.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"1072_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/annalsmedres.2023.07.169","volume":"30","author":"G Yucel","year":"2023","unstructured":"Yucel G, Gungor S. Evaluation of neurologically symptomatic and asymptomatic patients in childhood wilson\u2019s disease with central nervous system involvement: A retrospective observational study. Ann Med Res. 2023;30(8):1.","journal-title":"Ann Med Res"},{"issue":"3","key":"1072_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: wilson\u2019s disease. J Hepatol. 2012;56(3):671\u201385.","journal-title":"J Hepatol"},{"issue":"8","key":"1072_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","volume":"11","author":"KH Weiss","year":"2013","unstructured":"Weiss KH, Thurik F, Gotthardt DN, Sch\u00e4fer M, Teufel U, Wiegand F, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11(8):1028\u2013e10352.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1072_CR25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/MEG.0000000000002387","volume":"34","author":"KH Weiss","year":"2022","unstructured":"Weiss KH, Kruse C, Manolaki N, Zuin M, Ferenci P, Van Scheppingen D, et al. Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine. Eur J Gastroenterol Hepatol. 2022;34(9):940\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"1072_CR26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S2468-1253(22)00270-9","volume":"7","author":"ML Schilsky","year":"2022","unstructured":"Schilsky ML, Czlonkowska A, Zuin M, Cassiman D, Twardowschy C, Poujois A, et al. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. Lancet Gastroenterol Hepatol. 2022;7(12):1092\u2013102.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1072_CR27","doi-asserted-by":"crossref","unstructured":"Roberts EA. Trientine for Wilson Disease: Contemporary Issues. In: Wilson Disease [Internet]. Elsevier; 2019 [cited 2025 Jan 21]. pp. 187\u201395. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128110775000177","DOI":"10.1016\/B978-0-12-811077-5.00017-7"},{"issue":"12","key":"1072_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s40265-024-02099-0","volume":"84","author":"COF Kamlin","year":"2024","unstructured":"Kamlin COF, Jenkins M, Heise TL, Amin JS. Trientine tetrahydrochloride, from bench to bedside: A narrative review. Drugs. 2024;84(12):1509\u201318.","journal-title":"Drugs"},{"issue":"2","key":"1072_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ncl.2020.01.005","volume":"38","author":"C Mulligan","year":"2020","unstructured":"Mulligan C, Bronstein JM. Wilson disease. Neurol Clin. 2020;38(2):417\u201332.","journal-title":"Neurol Clin"},{"issue":"2","key":"1072_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0022-3476(96)70412-2","volume":"128","author":"EE Santos Silva","year":"1996","unstructured":"Santos Silva EE, Sarles J, Buts JP, Sokal EM. Successful medical treatment of severely decompensated Wilson disease. J Pediatr. 1996;128(2):285\u20137.","journal-title":"J Pediatr"},{"issue":"4","key":"1072_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/lt.20352","volume":"11","author":"A Dhawan","year":"2005","unstructured":"Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson\u2019s disease in children: 37-Year experience and revised king\u2019s score for liver transplantation. Liver Transpl. 2005;11(4):441\u20138.","journal-title":"Liver Transpl"},{"issue":"6","key":"1072_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-2143(03)00157-4","volume":"142","author":"FK Askari","year":"2003","unstructured":"Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. Treatment of wilson\u2019s disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med. 2003;142(6):385\u201390.","journal-title":"J Lab Clin Med"},{"issue":"6","key":"1072_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40846-015-0087-7","volume":"35","author":"JC Chen","year":"2015","unstructured":"Chen JC, Chuang CH, Wang JD, Wang CW. Combination therapy using chelating Agechennt and zinc for wilson\u2019s disease. J Med Biol Eng. 2015;35(6):697\u2013708.","journal-title":"J Med Biol Eng"},{"issue":"3","key":"1072_CR34","doi-asserted-by":"publisher","first-page":"101372","DOI":"10.1016\/j.jceh.2024.101372","volume":"14","author":"B Jagadisan","year":"2024","unstructured":"Jagadisan B, Dhawan A. Combination treatment with chelators and zinc for Wilson disease: A Double-edged sword. J Clin Exp Hepatol. 2024;14(3):101372.","journal-title":"J Clin Exp Hepatol"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01072-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:39:38Z","timestamp":1781613578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-025-01072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01072-1","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by UC Davis Institutional Review Board and surveyed physicians provided their consent to participate to the study (protocol #2022217-1)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}